Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients' survival in gastric adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neoplasma (Bratislava)

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4149/NEO_2014_040PMID 24824933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet Activating Factor

  2015cited by this paper
• Molecular link mechanisms between inflammation and cancer.

  2012cited by this paper
• Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.

  2012cited by this paper
• Multifactorial etiology of gastric cancer.

  2012cited by this paper
• Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma

  2012cited by this paper
• Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

  2011cited by this paper
• MCM-2 and MCM-5 Expression in Gastric Adenocarcinoma: Clinical Significance and Comparison with Ki-67 Proliferative Marker

  2011cited by this paper
• Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

  2010cited by this paper
• Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy

  2010cited by this paper
• Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium

  2010cited by this paper
• The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses.

  2010cited by this paper
• – Friends or Foes ?

  2010cited by this paper
• Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival

  2009cited by this paper
• Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN.

  2009cited by this paper
• Expression and Clinical Significance of Focal Adhesion Kinase in the Two Distinct Histological Types, Intestinal and Diffuse, of Human Gastric Adenocarcinoma

  2009cited by this paper
• The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants.

  2009cited by this paper
• Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis*

  2009cited by this paper
• Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases.

  2009cited by this paper
• PAF-R dependent pathways control tumor growth and tumor response to chemotherapy

  2009cited by this paper
• Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.

  2008influential reference
• The role of platelet-activating factor in the mammalian female reproductive tract.

  2008cited by this paper
• Emerging Roles of PAR-1 and PAFR in Melanoma Metastasis

  2008influential reference
• Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

  2008cited by this paper
• Expression of Platelet-Activating Factor Receptor: A Novel Prognosticator in Patients with Hepatocellular Carcinoma following Hepatectomy

  2008influential reference
• Inflammation and melanoma growth and metastasis: The role of platelet-activating factor (PAF) and its receptor

  2007cited by this paper
• Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-κB Activation

  2006cited by this paper
• Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086

  2006cited by this paper
• Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma.

  2006cited by this paper
• Platelet‐activating factor and human meningiomas

  2006cited by this paper
• Gastric cancer: global pattern of the disease and an overview of environmental risk factors.

  2006influential reference
• Platelet‐activating factor and liver metastasis of colorectal cancer

  2005cited by this paper
• Platelet-activating factor and human thyroid cancer.

  2005influential reference
• Interaction of tumor cells with vascular endothelia: Role of platelet-activating factor

  2004cited by this paper
• Augmentation of Chemotherapy-Induced Cytokine Production by Expression of the Platelet-Activating Factor Receptor in a Human Epithelial Carcinoma Cell Line1

  2004cited by this paper
• Diverse proteomic alterations in gastric adenocarcinoma

  2004cited by this paper
• Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth.

  2003cited by this paper
• The Epidermal Platelet-activating Factor Receptor Augments Chemotherapy-induced Apoptosis in Human Carcinoma Cell Lines*

  2003cited by this paper
• Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients

  2003influential reference
• Gastric cancer.

  2003cited by this paper
• Platelet-activating factor receptor.

  2002cited by this paper
• Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells

  2002cited by this paper
• Is there a role of platelet-activating factor in human lung cancer?

  2001cited by this paper
• G-protein-independent Activation of Tyk2 by the Platelet-activating Factor Receptor*

  2001cited by this paper
• Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.

  2000cited by this paper
• PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.

  2000cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Potential angiogenic role of platelet-activating factor in human breast cancer.

  1998influential reference
• VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor.

  1997cited by this paper
• Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet‐activating factor receptor

  1997cited by this paper
• Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.

  1997cited by this paper
• [Gastric cancer].

  1996cited by this paper
• Platelet-activating factor receptor: gene expression and signal transduction.

  1995cited by this paper
• Platelet-activating factor receptor.

  1995cited by this paper
• Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A.

  1994cited by this paper
• Platelet activating factor induces expression of early response genes c-fos and TIS-1 in human epidermoid carcinoma A-431 cells.

  1991cited by this paper
• Platelet-activating factor.

  1990cited by this paper
• Elevated plasma levels of platelet-activating factor (PAF) in breast cancer patients with hypercalcemia.

  1989cited by this paper
• Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis.

  1989cited by this paper
• Molecular pathobiology of acetyl glyceryl ether phosphorylcholine: evidence for the structural and functional identity with platelet-activating factor.

  1980cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

  1965cited by this paper

• Generation and multiomic profiling of a TP53/CDKN2A double-knockout gastroesophageal junction organoid model

  2022cites this paper
• Novel tumorigenic FOXM1-PTAFR-PTAF axis revealed by multi-omic profiling in TP53/CDKN2A-double knockout human gastroesophageal junction organoid model

  2022cites this paper
• α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.

  2022cites this paper
• mGWAS identification of six novel single nucleotide polymorphism loci with strong correlation to gastric cancer

  2021cites this paper
• Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease

  2020cites this paper
• The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

  2019cites this paper
• Platelet-Activating Factor Receptor Ligands Protect Tumor Cells from Radiation-Induced Cell Death

  2018cites this paper
• Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy

  2018cites this paper
• High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma.

  2017cites this paper
• Platelet-activating factor receptor activation promotes prostate cancer cell growth, invasion and metastasis via ERK1/2 pathway.

  2016cites this paper
• Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer

  2016cites this paper